Notify me when Megiddo Dalia files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| NSRX | Nasus Pharma Ltd. | Ordinary Shares | 20.9% | $14.3M | 1.89M | Dr. Dalia Megiddo | 30 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|